Structural Genomix Hires Away Millennium and Novartis Execs | GenomeWeb

NEW YORK, Jan 24 – Structural Genomix said Wednesday it has made two high-profile hires, naming Janice Culpepper, a senior technology executive at Millennium Pharmaceuticals, to the position of vice president of genomics and drug discovery and Doug Livingston, formerly of Novartis, to the position of vice president of chemistry and new technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.